Polypill

Polypill Limited is a pharmaceutical research and development company focused on the commercialization of the "Polypill" concept for the prevention of cardiovascular disease. Founded by Sir Nicholas Wald and Malcolm Law, the company pioneered the strategy of combining multiple cardiovascular medications—such as statins, aspirin, and antihypertensives—into a single daily pill to improve patient adherence and reduce the global burden of heart disease. The company's work involves clinical research, intellectual property management, and collaborations with global pharmaceutical manufacturers to bring these multi-component therapies to market. Their approach is considered a landmark in preventive medicine, aiming to provide a cost-effective solution for primary and secondary prevention of heart attacks and strokes.